Last Update: Sep 23, 2022.

Submitted by: Jazmin Blodget
Score: 66/100 (67 votes)

Which Covid vaccine is better for older adults?

People 65 and older who received both doses of either Pfizer or Moderna vaccines showed a 94% reduced risk of COVID-19 related hospitalization. Unvaccinated people should get vaccinated and continue masking until they are fully vaccinated. With the Delta variant, this is more urgent than ever.

Yes, depending on your age, you can choose which COVID-19 vaccine to get. For adults ages 18 years and older, the mRNA COVID-19 vaccines (Pfizer-BioNTech or Moderna) are preferred over Johnson Johnson’s Janssen (J J/Janssen) COVID-19 vaccine. You may get J J/Janssen COVID-19 vaccine in some situations.n Currently, Pfizer-BioNTech COVID-19 vaccine is the only COVID-19 vaccine available to children ages 5 through 17 years old.n Learn more about your COVID-19 vaccination, including how to find a vaccination location, what to expect at your appointment, and more.

Moderna yesterday asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 18 and older who received an initial booster of any authorized or approved COVID-19 vaccine, citing published data from the United States and Israel after the omicron variant emerged.

nEveryone 5 years or older is eligible for a COVID-19 vaccine in New Jersey and encouraged to get vaccinated as soon as possible. All adults (18 and older) are eligible for the two-dose Pfizer, two-dose Moderna or one-dose Johnson Johnson vaccines.n

Moderna COVID-19 Vaccine Overview And Safety

nCDC does not recommend mixing products for a two-dose primary series or additional primary doses. For a booster dose, adults ages 18 years and older may choose which vaccine product they get. CDC recommends either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most circumstances.n

Moderna COVID-19 Vaccine Overview And Safety

nThe Pfizer-BioNTech COVID-19 vaccine is FDA-approved for use as a two-dose series administered 21 days apart to adolescents and adults 16 years and older and is authorized for emergency use in children ages 12-15 using the same schedule.n

The vaccine is safe and effective for all individuals aged 18 and above. In line with the WHO Prioritization Roadmap and the WHO Values Framework, older adults, health workers and immunocompromised persons should be prioritised. This vaccine can be offered to people who have had COVID-19 in the past.

1. The Moderna COVID-19 Vaccine is authorized for use in individuals 18 years of age and older.

Spikevax And Moderna COVID-19 Vaccine

On January 31, 2022, the FDA announced the second approval of a COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine, and will now be marketed as Spikevax, for the prevention of COVID-19 in individuals 18 years of age and older.

Spikevax And Moderna COVID-19 Vaccine

In November 2017, a vaccine was approved by the FDA for use in the U.S. Heplisav-B (Dynavax) is a two-dose vaccine approved for use in adults aged 18 and older. The vaccine is administered as two doses given one-month apart. Ask your doctor about the 2-dose vaccine.

nnCDC recommends everyone ages 5 years and older get a COVID-19 vaccine to help protect against COVID-19.nn

Vaccine effectiveness is expected to be similar in lactating women as in other adults. WHO recommends the use of the COVID-19 vaccine Sinovac-CoronaVac in lactating women as in other adults. WHO does not recommend discontinuing breastfeeding after vaccination.

COVID-19 Vaccination For Children 5-11 Years Old

Children 5 years and older can get the Pfizer-BioNTech COVID-19 Vaccine. Children 5 through 11 years old will receive a separate vaccine formulation denoted with an orange cap of the Pfizer-BioNTech COVID-19 Vaccine, and will receive the vaccine with a smaller needle.

COVID-19 Vaccination For Children 5-11 Years Old

Comirnaty is a monovalent COVID-19 vaccine that is approved for use as a two-dose primary series for the prevention of COVID-19 in individuals 12 years of age and older.

CDC recommends pneumococcal vaccination for all adults 65 years or older. The tables below provide detailed information. For adults 65 years or older who have not previously received any pneumococcal vaccine, CDC recommends you: Give 1 dose of PCV15 or PCV20.